Market Overview:
The global aminoglycosides antibiotics market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The hospital segment is expected to hold the dominant share in the global aminoglycosides antibiotics market by 2030. North America is estimated to be the leading region for the global aminoglycosides antibiotics market in 2018 and Asia Pacific is projected to be the fastest growing region during the forecast period. Some of key factors driving growth of this market include rising incidence of infectious diseases, increasing demand for better healthcare infrastructure, and technological advancements in medical devices & equipment. However, stringent regulatory policies and side effects associated with use of these drugs are some factors restraining growth of this market.
Product Definition:
Aminoglycosides antibiotics are a class of drugs that kill or stop the growth of bacteria. They work by preventing the bacteria from making proteins, which they need to survive. This group of antibiotics includes amikacin, gentamicin, kanamycin, neomycin, and streptomycin.
Neomycin:
Neomycin, also known as Streptomycin, is an antibiotic used to treat bacterial infections. It was first discovered in the early 1940s and has been a mainstay in the treatment of tuberculosis ever since. Neomycin finds application across a wide range of medical disciplines including gynecology, pulmonary medicine, dermatology and more.
Tobramycin:
Tobramycin is an aminoglycoside antibiotic. It works by inhibiting protein synthesis in the bacterial cell. Tobramycin has a broad spectrum of antimicrobial activity and is effective against many gram-positive and negative bacteria, including staphylococci, enteric bacilli, mycotic organisms (i.e., fungi), and certain enveloped viruses such as theenterovirus 71 & 74 (i.e.
Application Insights:
The hospital application segment led the market in 2017 and is projected to continue its dominance over the forecast period. Aminoglycosides antibiotics are used for various diseases, such as respiratory infections, skin infections, urinary tract infections (UTIs), and sepsis. The hospital application of aminoglycosides antibiotics has been witnessing a rise due to their increasing use in surgeries and treatment of severe pneumonia. Furthermore, rising healthcare spending by countries such as India and China is expected to propel product demand from 2018 to 2030.
Clinic applications include primary care settings or walk-in clinics that serve low-income populations or people with chronic diseases who would otherwise seek medical care at hospitals or emergency rooms. These antibiotic medicines are also used for skin conditions outside of the body where there is no visible infection; this includes on surfaces like furniture where bacteria can get onto clothing or other objects that people touch after coming into contact with infected individuals.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to witness substantial growth over the forecast period. This can be attributed to increasing healthcare expenditure, rising awareness about antibiotic resistance, and growing need for cost-effective drugs. Moreover, favorable government initiatives such as “One Health†programs are also anticipated to drive demand for aminoglycosides in this region. For instance, One Health Malaysia organized a conference on Emerging Diseases & Control Strategies held from 23rd April - 25th April 2018 at Sunway Lagoon Hotel & Convention Centre, Petaling Jaya Malaysia.
In addition it has been observed that countries like India have started collaborating with international organizations such as WHO and PAHO for monitoring antimicrobial resistance patterns across various regions of South East Asia including India China Pakistan Thailand Philippines Indonesia Myanmar Bangladesh Sri Lanka etc.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the major growth drivers for the global aminoglycosides antibiotics market. This is because infections caused by bacteria are becoming more common and resistant to traditional antibiotics, which has led to an increase in the demand for aminoglycosides antibiotics.
- Rising prevalence of multidrug-resistant bacteria: The rising prevalence of multidrug-resistant bacteria is another key factor that is expected to drive the growth of the global aminoglycosides antibiotics market in the coming years. This is because these strains are resistant to most traditional antibiotics, making aminoglycosides one of few remaining treatment options available for patients suffering from such infections.
- Growing awareness about antibiotic resistance: There has been a growing awareness about antibiotic resistance in recent years, which has led to an increased demand for novel and effective antimicrobial drugs such as aminoglycosides antibiotics. This trend is likely to continue in the coming years, thereby propelling the growth of this market segment further.
Scope Of The Report
Report Attributes
Report Details
Report Title
Aminoglycosides Antibiotics Market Research Report
By Type
Neomycin, Tobramycin, Gentamicin, Amikacin, Etimicin, Others
By Application
Hospital, Clinic, Post Care Facility, Government & Military, Others
By Companies
Jemicare, Teva, Novartis, Fangyuan-pharma, Aike Pharmaceutical, Cipla, Pfizer, Fresenius Kabi, Sun Pharma, Hikma, Lannett Company
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
166
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global Aminoglycosides Antibiotics Market Report Segments:
The global Aminoglycosides Antibiotics market is segmented on the basis of:
Types
Neomycin, Tobramycin, Gentamicin, Amikacin, Etimicin, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Post Care Facility, Government & Military, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Jemicare
- Teva
- Novartis
- Fangyuan-pharma
- Aike Pharmaceutical
- Cipla
- Pfizer
- Fresenius Kabi
- Sun Pharma
- Hikma
- Lannett Company
Highlights of The Aminoglycosides Antibiotics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Neomycin
- Tobramycin
- Gentamicin
- Amikacin
- Etimicin
- Others
- By Application:
- Hospital
- Clinic
- Post Care Facility
- Government & Military
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Aminoglycosides Antibiotics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Aminoglycosides antibiotics are a type of antibiotic that is derived from the amino acid aminoguanidine. They are effective against a variety of bacteria, including some types of tuberculosis (TB). Aminoglycosides antibiotics can be taken by mouth or by injection.
Some of the major companies in the aminoglycosides antibiotics market are Jemicare, Teva, Novartis, Fangyuan-pharma, Aike Pharmaceutical, Cipla, Pfizer, Fresenius Kabi, Sun Pharma, Hikma, Lannett Company.
The aminoglycosides antibiotics market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Aminoglycosides Antibiotics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Aminoglycosides Antibiotics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Aminoglycosides Antibiotics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Aminoglycosides Antibiotics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Aminoglycosides Antibiotics Market Size & Forecast, 2020-2028
4.5.1 Aminoglycosides Antibiotics Market Size and Y-o-Y Growth
4.5.2 Aminoglycosides Antibiotics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Neomycin
5.2.2 Tobramycin
5.2.3 Gentamicin
5.2.4 Amikacin
5.2.5 Etimicin
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Post Care Facility
6.2.4 Government & Military
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Aminoglycosides Antibiotics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Aminoglycosides Antibiotics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Neomycin
9.6.2 Tobramycin
9.6.3 Gentamicin
9.6.4 Amikacin
9.6.5 Etimicin
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Post Care Facility
9.10.4 Government & Military
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Neomycin
10.6.2 Tobramycin
10.6.3 Gentamicin
10.6.4 Amikacin
10.6.5 Etimicin
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Post Care Facility
10.10.4 Government & Military
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Neomycin
11.6.2 Tobramycin
11.6.3 Gentamicin
11.6.4 Amikacin
11.6.5 Etimicin
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Post Care Facility
11.10.4 Government & Military
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Neomycin
12.6.2 Tobramycin
12.6.3 Gentamicin
12.6.4 Amikacin
12.6.5 Etimicin
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Post Care Facility
12.10.4 Government & Military
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Neomycin
13.6.2 Tobramycin
13.6.3 Gentamicin
13.6.4 Amikacin
13.6.5 Etimicin
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Post Care Facility
13.10.4 Government & Military
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Aminoglycosides Antibiotics Market: Competitive Dashboard
14.2 Global Aminoglycosides Antibiotics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Jemicare
14.3.2 Teva
14.3.3 Novartis
14.3.4 Fangyuan-pharma
14.3.5 Aike Pharmaceutical
14.3.6 Cipla
14.3.7 Pfizer
14.3.8 Fresenius Kabi
14.3.9 Sun Pharma
14.3.10 Hikma
14.3.11 Lannett Company
